Advertisement

Isolating tumour suppressor genes relevant to ovarian carcinoma — the role of loss of heterozygosity

  • W. D. Foulkes
  • J. Trowsdale

Abstract

Despite the increasing use of chemotherapeutic regimens that achieve high rates of response, the long term outlook for patients with ovarian carcinoma remains dismal. The all-stage five year survival is about 28% and has not improved in the last decade or more [1]. It has become clear that new strategies are required and uncovering genes whose aberrant function can be demonstrated in ovarian carcinoma may have important diagnostic and therapeutic implications.

Keywords

Ovarian Cancer Ovarian Carcinoma Retinitis Pigmentosa Human Ovarian Cancer Frequent Loss 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Slevin, M.L. (1986) Ovarian cancer, in Randomised Trials in Cancer, — A Critical Review by Sites, (eds M.L. Slevin and J. Staquet), Raven Press, New York, pp. 385–416.Google Scholar
  2. 2.
    Harris, H., Miller, O.J., Klein, G. et al, (1969) Suppression of malignancy by cell fusion. Nature, 223, 363–8.PubMedCrossRefGoogle Scholar
  3. 3.
    Saxon, P.J., Srivatsan, E.S. and Stanbridge, E.J. (1986) Introduction of human chromosome 11 via microcell transfer controls tumorigenic expression in Hella cells. EMBO J, 5, 3461–6.PubMedGoogle Scholar
  4. 4.
    Gelehrter, T.D. and Collins, F.S. (1990) Principles of Medical Genetics, Williams and Wilkins, Baltimore.Google Scholar
  5. 5.
    Yunis, J.J. and Ramsay, N. (1978) Retino blastema and a subband deletion of chromosome 13. Am. J. Dis. Child., 132, 161–3.PubMedGoogle Scholar
  6. 6.
    Strong, L.C., Riccardi, V.M., Ferrell, R.E. and Sparkes, R.S. (1981) Familial retinoblastoma and chromosomal deletion transmitted via an insertional translocation. Science, 213, 1501–3.PubMedCrossRefGoogle Scholar
  7. 7.
    Benedict, W.F., Murphree, A.L., Banerjee, A. et al., (1983) Patient with chromosome 13 deletion: evidence that the retinoblastoma gene is a recessive cancer gene. Science, 289, 973–5.CrossRefGoogle Scholar
  8. 8.
    DeMars, R. (1970) In 23rd Annual Symposium, Fundamental cancer research 1969. Williams and Wilkins, Baltimore, pp. 105–6.Google Scholar
  9. 9.
    Knudson, A.C. (1971) Mutation and cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA, 68, 820–3.PubMedCrossRefGoogle Scholar
  10. 10.
    Comings, D. (1973) A general theory of carcinogenesis. Proc. Natl. Acad. Sci. USA, 70, 3324–8.PubMedCrossRefGoogle Scholar
  11. 11.
    Knudson, A.C. (1978) Retinoblastoma: a prototypic hereditary neoplasm.Semin. Oncol., 5, 57–60.PubMedGoogle Scholar
  12. 12.
    Sparkes, R.S., Murphree, A.L., Lingua, R.W. et al., (1983) Gene for hereditary retinoblastoma assigned to human chromosome 13 by linkage to Esterase D. Science, 289,971–3.CrossRefGoogle Scholar
  13. 13.
    Kan, Y.W. and Dozy, A.M. (1978) Polymorphism of DNA sequence adjacent to human β, haemoglobin structural gêüe: relationship to sickle mutation. Proc. Natl Acad. Sci. USA, 75, 5631–5.PubMedCrossRefGoogle Scholar
  14. 14.
    Solomon, E. and Bodmef, W.F. (1979) Evolution of a sickle variant gene. Lancet, i, 923.CrossRefGoogle Scholar
  15. 15.
    Cavenee, W.B., Dryja, T.P., Phillips, R.A. et al, (1983) Expression of recessive alleles by chromosomal mechanism in retinoblastoma. Nature, 305, 779–84.PubMedCrossRefGoogle Scholar
  16. 16.
    Friend, S.H., Bernards, R., Rogelj, S. et al, (1986) A human DNA segment with properties of a gene that predisposes to retinoblastoma and osteosarcoma. Nature, 323,643–6.PubMedCrossRefGoogle Scholar
  17. 17.
    Vogelstein, B., Fearon, E.R., Hamilton, S.R. et al, (1988) Genetic alterations during colorectal tumor development. N. Engl J. Med., 319, 525–32.PubMedCrossRefGoogle Scholar
  18. 18.
    Powell, D.E., Puis, L. and van Nagell, J. (1992) Current concepts in epithelial ovarian tumours: does benign to malignant transformation occur? Hum. Pathol., 23, 846–7.PubMedCrossRefGoogle Scholar
  19. 19.
    Ballabio, A. (1993) The rise and fall of positional cloning? Nature Genet., 3, 277–9.PubMedCrossRefGoogle Scholar
  20. 20.
    Dryja, T.P., McGee, T.L., Reichel, E. et al, (1990) A point mutation of the rhodopsin gene in one form of retinitis pigmentosa. Nature, 343,364–6.PubMedCrossRefGoogle Scholar
  21. 21.
    Hartwell, L. (1992) Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell, 71, 543–6.PubMedCrossRefGoogle Scholar
  22. 22.
    Fearon, E.R. and Vogelstein, B. (1990) A genetic model for colorectal tumourigenesis. Cell, 61, 759–67.PubMedCrossRefGoogle Scholar
  23. 23.
    Gallion, H.H., Powell, D.E., Morrow, J.K. et al, (1992) Molecular genetic changes in human epithelial ovarian malignancies. Gynecol Oncol., 47,137–42.PubMedCrossRefGoogle Scholar
  24. 24.
    Eccles, D.M., Russell, S.E.H., Haites, N.E and the ABE Ovarian Cancer Genetics Group (1992) Early loss of heterozygosity in ovarian cancer.Oncogene, 7, 2069–72.PubMedGoogle Scholar
  25. 25.
    Sasano, H., Comerford, J., Silverberg, S.G. and Garrett, C.T. (1990) An analysis of abnormal ities of the retinoblastoma gene in human ovarian and endometrial carcinoma. Cancer, 66, 2150–4.PubMedCrossRefGoogle Scholar
  26. 26.
    Li S-B., Schwartz, P.E., Lee, W-H. and Yang-Feng, T.L. (1991) Allele loss at the retinoblastoma locus in human ovarian cancer. J. Natl Cancer Inst., 83, 637–40.PubMedCrossRefGoogle Scholar
  27. 27.
    Jacobs, LJ., Kohier, M.F., Wiseman, R.W. et al, (1992) Clonal origin of epithehal ovarian carcinoma: analysis by loss of heterozygosity, p53 mutation and X-chromosome inactivation. J. Natl Cancer Inst., 84,1793–8.PubMedCrossRefGoogle Scholar
  28. 28.
    Chenevix-Trench, G., Leary, J., Kerr, J. et al, (1992) Frequent loss of heterozygosity on chromosome 18 in ovarian adenocarcinoma which does not always include the DCC locus. Oncogene, 7,1059–65.PubMedGoogle Scholar
  29. 29.
    Lee, J.H., Kavanagh, J.J., Wharton, J.T. et al, (1989) Allele loss at the c-Ha-rasl locus in human ovarian cancer. Cancer Res., 49, 1220–2.PubMedGoogle Scholar
  30. 30.
    Okamoto, A., Sameshima, Y., Yokoyama, S. et al, (1991) Frequent allelic losses and mutations of the p53 gene in human ovarian cancer. Cancer Res., 51,5171–6.PubMedGoogle Scholar
  31. 31.
    Marks, J.R., Davidoff, A.M., Kerns, B.J. et al, (1991) Overexpression and mutation of p53 in epithelial ovarian cancer. Cancer Res., 61, 2979–84.Google Scholar
  32. 32.
    Sato, T., Saito, H., Morita, R. et al, (1991) Allelotype of human ovarian cancer. Cancer Res., 51, 5118–22.PubMedGoogle Scholar
  33. 33.
    Lee, J.H., Kavanagh, J.J., Wildrick, D.M. et al, (1990) Frequent loss of heterozygosity on chromosomes 6q, 11 and 17 in human ovarian carcinomas. Cancer Res., 50, 2724–8.PubMedGoogle Scholar
  34. 34.
    Ehlen, T. and Dubeau, L. (1990) Loss of heterozygosity on chromosomal segments 3p, 6q and lip in human ovarian cancer. Oncogene, 5, 219–23.PubMedGoogle Scholar
  35. 35.
    Zheng, J., Robinson, W.R., Ehlen, T. et al, (1991) Distinction of low grade from high grade human ovarian carcinomas on the basis of losses of heterozygosity on chromosomes 3, 6 and 11 and HER-2/neu, gene amplification. Cancer Res., 51, 4045–51.PubMedGoogle Scholar
  36. 36.
    Jones, M.H. and Nakamura, Y. (1992) Deletion mapping of chromosome 3p in female genital tract malignancies using microsatellite polymorphisms. Oncogene, 7,1631–4.PubMedGoogle Scholar
  37. 37.
    Saito, S., Saito, H., Koi, S. et al, (1992) Fine scale deletion mapping of the distal long arm of chromosome 6 in 70 human ovarian cancers. Cancer Res., 52, 5815–17.PubMedGoogle Scholar
  38. 38.
    Yang-Feng, T.L., Li, S-B., Han, H. and Schwartz, P.E. (1992) Frequent loss of heterozygosity on chromosome Xp and 13q in human ovarian cancer.Int. J. Cancer, 52,575–80.PubMedCrossRefGoogle Scholar
  39. 39.
    Foulkes, W.D., Ragoussis, J., Stamp, G.W.H. et al, (1993) Frequent loss of heterozygosity on chromosome 6 in human ovarian carcinoma. Br. J. Cancer, 67, 551–9.PubMedCrossRefGoogle Scholar
  40. 40.
    Vandamme, B., Lissens, W., Amfo, K. et al, (1992) Deletion of chromosome Ilpl3-llpl5.5 sequences in invasive human ovarian cancer is a subclonal progression factor. Cancer Res., 52, 6646–52.PubMedGoogle Scholar
  41. 41.
    Viel, A., Giannini, F., Tumiotti, L. et al, (1992) Chromosomal localisation of two putative oncosuppressor genes involved in human ovarian tumours. Br. J. Cancer, 66, 1030–6.PubMedCrossRefGoogle Scholar
  42. 42.
    Foulkes, W.D., Campbell, I.G., Stamp, G.W.H. and Trowsdale, J. (1993) Loss of heterozygosity and amplification of chromosome 11 in human ovarian cancer. Br., J,. Cancer, 67, 268–73.PubMedCrossRefGoogle Scholar
  43. 43.
    Eccles, D.M., Gruber, L., Stewart, M. et al., (1992) Allele loss on chromosome lip is associated with poor survival in ovarian carcinoma. Dis. Markers, 10,95–9.PubMedGoogle Scholar
  44. 44.
    Tsao, S.W., Mok, C-H., Oike, K. et al, (1991) Involvement of p53 gene in the allelic deletion of chromosome 17p in human ovarian tumours. Anticancer Res., 11, 1975–82.PubMedGoogle Scholar
  45. 45.
    Eccles, D.M., Brett, L., Lessells, A. et al, (1992) Overexpression of the p53 protein and allele loss at 17pl3 in ovarian carcinoma. Br. J. Cancer, 65, 40–4.PubMedCrossRefGoogle Scholar
  46. 46.
    Foulkes, W.D., Black, D.M., Stamp, G.W.H. et al, (1993) Very frequent loss of heterozygosity throughout chromosome 17 in sporadic ovarian carcinoma. Int. J. Cancer, 54, 220–6.PubMedCrossRefGoogle Scholar
  47. 47.
    Jacobs, I.J., Smith, S.A., Wiseman, R.W. et al, (1993) A deletion unit on chromosome 17q in epithelial ovarian tumors distal to the familial breast/ovarian cancer locus. Cancer Res., 53, 1218–21.PubMedGoogle Scholar
  48. 48.
    Phillips, N., Ziegler, M., Saha, B. and Xynos, F. (1993) Allelic loss on chromosome 17 in human ovarian carcinoma. Int., J. Cancer, 54, 85–91.PubMedCrossRefGoogle Scholar
  49. 49.
    Allan, G.J., Cottrell, S., Trowsdale, J. and Foulkes, W.D. (1994) Loss of heterozygosity on chromosome 5 is a late event and is not associated with mutations in APC at 5q21–22. Hum. Mutation, 3, 283–92.CrossRefGoogle Scholar
  50. 50.
    Bruening, W., Gross, P., Sato, T. et al, (1993) Analysis of the 11 pi 3 Wilms’ tumour suppressor gene (WTl) in ovarian tumours.Cancer Invest., 11, 393–9.PubMedCrossRefGoogle Scholar

Copyright information

© Chapman & Hall 1995

Authors and Affiliations

  • W. D. Foulkes
  • J. Trowsdale

There are no affiliations available

Personalised recommendations